Compass Therapeutics, Inc. Award Timing Disclosure Disclosure
10-KFiled Mar 5, 20261 min read
Item 11. Executive Compensation.
The information required by this Item 11 will be included in our Definitive Proxy Statement to be filed with the SEC with respect to our 2026 Annual Meeting of Stockholders and is incorporated herein by reference.